This was well in concordance with its proposed role of tumor suppressor, backed up primarily by gene expression studies where low expression of AZGP1 is associated with a higher risk of aggressive time-dependent outcomes in PCa [60,61,62,63]. The gene discussed is AZGP1; the disease is neoplasm.